Walleye Capital LLC Halozyme Therapeutics, Inc. Put Options Transaction History

Walleye Capital LLC

11 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$51.3 - $64.42 $241,110 - $302,774	4,700 Added 167.86%	7,500 $429,000
Q2 2024 Aug 14, 2024	SELL	$37.81 - $52.4 $117,211 - $162,440	-3,100 Reduced 52.54%	2,800 $146,000
Q1 2024 May 15, 2024	BUY	$33.68 - $41.95 $134,720 - $167,800	4,000 Added 210.53%	5,900 $240,000
Q4 2023 Feb 14, 2024	SELL	$33.32 - $42.1 $96,628 - $122,090	-2,900 Reduced 60.42%	1,900 $70,000
Q3 2023 Nov 14, 2023	SELL	$36.46 - $44.03 $218,760 - $264,180	-6,000 Reduced 55.56%	4,800 $183,000
Q2 2023 Aug 14, 2023	BUY	$30.28 - $38.74 $327,024 - $418,392	10,800 New	10,800 $389,000
Q4 2022 Feb 14, 2023	BUY	$40.06 - $59.44 $1.13 Million - $1.67 Million	28,100 Added 550.98%	33,200 $1.89 Million
Q3 2022 Nov 14, 2022	BUY	$38.53 - $51.78 $196,503 - $264,078	5,100 New	5,100 $202,000
Q4 2019 Feb 14, 2020	SELL	$14.93 - $19.53 $65,692 - $85,932	-4,400 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$15.2 - $17.69 $287,280 - $334,341	-18,900 Reduced 81.12%	4,400 $68,000
Q2 2019 Aug 14, 2019	BUY	$14.75 - $17.26 $343,675 - $402,158	23,300 New	23,300 $400,000

544

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.75B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.